Search

everythinglearnresearchcommunity

for

Search:↓

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Cimetidine does not significantly reduce hair growth in hirsutism.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Laser hair removal effectively reduces hidradenitis suppurativa symptoms with few side effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Hantavirus survivors often face long-term health issues, needing ongoing care.

More research is needed to find effective treatments for sickle cell disease-related priapism.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Hippocampus sparing whole brain radiation therapy prevents hair loss and preserves cognitive function.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Inositol hexaphosphate helps protect hearing by preserving ear cells in mice.

Early recognition and treatment of hidradenitis suppurativa in children are crucial to prevent complications.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.